Muhammad Hasnat

1.2k total citations · 1 hit paper
24 papers, 1.0k citations indexed

About

Muhammad Hasnat is a scholar working on Molecular Biology, Biomaterials and Complementary and alternative medicine. According to data from OpenAlex, Muhammad Hasnat has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Biomaterials and 5 papers in Complementary and alternative medicine. Recurrent topics in Muhammad Hasnat's work include Natural Compounds in Disease Treatment (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and RNA Interference and Gene Delivery (3 papers). Muhammad Hasnat is often cited by papers focused on Natural Compounds in Disease Treatment (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and RNA Interference and Gene Delivery (3 papers). Muhammad Hasnat collaborates with scholars based in China, Pakistan and Hong Kong. Muhammad Hasnat's co-authors include Muhammad Naveed, Mirza Muhammad Faran Ashraf Baig, Muhammad Sohail, Luyong Zhang, Zhenzhou Jiang, Ziqiao Yuan, Muzzamal Hussain, Qi‐Gang Zhou, Mohib Ullah Kakar and Tahir Mehmood Khan and has published in prestigious journals such as British Journal of Cancer, International Journal of Pharmaceutics and Journal of Ethnopharmacology.

In The Last Decade

Muhammad Hasnat

24 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chitosan oligosaccharide (COS): An overview

2019 386 citations Muhammad Naveed, Muhammad Sohail et al. International Journal of Biological Macromolecules profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Muhammad Hasnat China	14	394	321	160	150	86	24	1.0k
Jithendra Panneerselvam Malaysia	19	332 0.8×	298 0.9×	143 0.9×	168 1.1×	49 0.6×	36	1.2k
Ruifeng Luo China	19	434 1.1×	186 0.6×	128 0.8×	176 1.2×	64 0.7×	40	1.2k
Satish Patel India	15	334 0.8×	288 0.9×	53 0.3×	124 0.8×	55 0.6×	28	1.4k
Xin Nie China	17	431 1.1×	162 0.5×	101 0.6×	130 0.9×	45 0.5×	34	1.2k
Raghuram Kandimalla India	26	552 1.4×	389 1.2×	79 0.5×	309 2.1×	46 0.5×	59	1.6k
Sumel Ashique India	22	553 1.4×	237 0.7×	52 0.3×	256 1.7×	81 0.9×	134	1.5k
Changliang Xu China	21	394 1.0×	408 1.3×	112 0.7×	448 3.0×	48 0.6×	54	1.5k
Li Lv China	19	660 1.7×	320 1.0×	46 0.3×	143 1.0×	172 2.0×	52	1.3k
Suresh Kumar Anandasadagopan India	23	416 1.1×	224 0.7×	84 0.5×	231 1.5×	68 0.8×	53	1.2k
Jun Ye China	23	662 1.7×	238 0.7×	80 0.5×	202 1.3×	154 1.8×	67	1.7k

Countries citing papers authored by Muhammad Hasnat

Since Specialization

Citations

This map shows the geographic impact of Muhammad Hasnat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Hasnat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Hasnat more than expected).

Fields of papers citing papers by Muhammad Hasnat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Hasnat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Hasnat. The network helps show where Muhammad Hasnat may publish in the future.

Co-authorship network of co-authors of Muhammad Hasnat

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Hasnat. A scholar is included among the top collaborators of Muhammad Hasnat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Hasnat. Muhammad Hasnat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Qipeng, Muhammad Hasnat, Le Li, et al.. (2024). Oncofetal SNRPE promotes HCC tumorigenesis by regulating the FGFR4 expression through alternative splicing. British Journal of Cancer. 131(1). 77–89. 3 indexed citations

Qin, Tingting, Muhammad Hasnat, Hozeifa Mohamed Hassan, et al.. (2023). Geniposide alleviated bile acid-associated NLRP3 inflammasome activation by regulating SIRT1/FXR signaling in bile duct ligation-induced liver fibrosis. Phytomedicine. 118. 154971–154971. 23 indexed citations

Shi, Le, et al.. (2023). Anti-inflammatory Response and Detection of Pharmacologically Active Components in Serum of Rats with Carrageenan-Induced Paw Swelling Treated with Phellodendron chinense. Revista Brasileira de Farmacognosia. 34(2). 397–406. 1 indexed citations

Ullah, Aftab, Faisal Raza, Muhammad Hasnat, et al.. (2023). Hollow Mesoporous Silica Nanoparticles for Dual Chemo-starvation Therapy of Hepatocellular Carcinoma. Pharmaceutical Research. 40(9). 2215–2228. 12 indexed citations

Hasnat, Muhammad, et al.. (2023). 5-Azacytidine promotes HCC cell metastasis by up-regulating RDH16 expression. European Journal of Pharmacology. 950. 175736–175736. 4 indexed citations

Wu, Qipeng, et al.. (2022). Osteopontin promotes hepatocellular carcinoma progression through inducing JAK2/STAT3/NOX1-mediated ROS production. Cell Death and Disease. 13(4). 341–341. 47 indexed citations

Qin, Tingting, Muhammad Hasnat, Yang Zhou, Ziqiao Yuan, & Wenzhou Zhang. (2022). Macrophage malfunction in Triptolide-induced indirect hepatotoxicity. Frontiers in Pharmacology. 13. 981996–981996. 5 indexed citations

Hou, Shanshan, Muhammad Hasnat, Ziwei Chen, et al.. (2022). Application Perspectives of Nanomedicine in Cancer Treatment. Frontiers in Pharmacology. 13. 909526–909526. 13 indexed citations

Qin, Tingting, Ting Zhang, Yunyun Zhang, et al.. (2021). Total C-21 Steroidal Glycosides From Baishouwu Ameliorate Hepatic and Renal Fibrosis by Regulating IL-1β/MyD88 Inflammation Signaling. Frontiers in Pharmacology. 12. 775730–775730. 11 indexed citations

10.

Shi, Le, Ziqiao Yuan, Jing Liu, et al.. (2021). Modified Simiaowan prevents articular cartilage injury in experimental gouty arthritis by negative regulation of STAT3 pathway. Journal of Ethnopharmacology. 270. 113825–113825. 12 indexed citations

11.

Rasheed, Saim, et al.. (2021). Load Management System with Integration of Renewable Energy Resources. International Journal of Integrated Engineering. 13(6). 1 indexed citations

12.

Yuan, Ziqiao, Zihang Yuan, Muhammad Hasnat, et al.. (2020). A new perspective of triptolide-associated hepatotoxicity: the relevance of NF- B and NF- B-mediated cellular FLICE-inhibitory protein. Acta Pharmaceutica Sinica B. 10(5). 861–877. 35 indexed citations

13.

Raza, Faisal, Ying Zhu, Li Chen, et al.. (2019). Paclitaxel-loaded pH responsive hydrogel based on self-assembled peptides for tumor targeting. Biomaterials Science. 7(5). 2023–2036. 163 indexed citations

14.

Baig, Mirza Muhammad Faran Ashraf, Muhammad Abbas, Muhammad Naveed, et al.. (2019). Design, synthesis and evaluation of DNA nano-cubes as a core material protected by the alginate coating for oral administration of anti-diabetic drug. Journal of Food and Drug Analysis. 27(3). 805–814. 25 indexed citations

15.

Yuan, Ziqiao, Haoran Zhang, Muhammad Hasnat, et al.. (2019). A new perspective of triptolide-associated hepatotoxicity: Liver hypersensitivity upon LPS stimulation. Toxicology. 414. 45–56. 43 indexed citations

16.

Naveed, Muhammad, Muhammad Sohail, Muhammad Hasnat, et al.. (2019). Chitosan oligosaccharide (COS): An overview. International Journal of Biological Macromolecules. 129. 827–843. 386 indexed citations breakdown →

17.

Yuan, Ziqiao, Muhammad Hasnat, Zihang Yuan, et al.. (2019). The role of inflammasome activation in Triptolide-induced acute liver toxicity. International Immunopharmacology. 75. 105754–105754. 45 indexed citations

18.

Asifullah, Khan, Zhanwei Zhou, Weiming He, et al.. (2019). CXCR4-Receptor-Targeted Liposomes for the Treatment of Peritoneal Fibrosis. Molecular Pharmaceutics. 16(6). 2728–2741. 9 indexed citations

19.

Hasnat, Muhammad, Ziqiao Yuan, Muhammad Naveed, et al.. (2018). Drp1-associated mitochondrial dysfunction and mitochondrial autophagy: a novel mechanism in triptolide-induced hepatotoxicity. Cell Biology and Toxicology. 35(3). 267–280. 84 indexed citations

20.

Naveed, Muhammad, Lei Han, Muhammad Hasnat, et al.. (2018). Suppression of TGP on myocardial remodeling by regulating the NF-κB pathway. Biomedicine & Pharmacotherapy. 108. 1460–1468. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact